The Foundation for Sickle Cell Disease Research (FSCDR) has named Dr. Betty S. Pace as the inaugural Editor-in-Chief of the Journal of Sickle Cell Disease (JSCD), a newly launched peer-reviewed, open-access journal published in collaboration with Oxford University Press.

Dr. Pace is a leading physician-scientist and the Francis J. Tedesco Distinguished Chair of Pediatric Hematology/Oncology at Augusta University. With over 30 years of NIH-funded research experience, she brings deep expertise in drug discovery and molecular therapies for sickle cell disease (SCD).
“The Journal of Sickle Cell Disease is designed to rapidly share high-quality, open-access research with clinicians, scientists, patients, and advocates,” said Dr. Pace. “Our goal is to foster innovation, promote collaboration, and accelerate solutions for the global sickle cell community.”
JSCD covers a wide spectrum of topics—from basic and translational science to clinical and implementation research—aiming to serve as a leading platform for advancing knowledge and care in SCD.
“Dr. Pace has helped shape our scientific agenda since the Foundation’s founding,” said Dr. Lanetta Bronté-Hall, Founding Editor of JSCD and President of FSCDR. “Her leadership and vision will ensure the journal becomes a vital tool for researchers worldwide.”
The journal’s editorial board features internationally respected experts committed to advancing sickle cell scholarship and impact through rigorous peer review and open access.
About the Foundation for Sickle Cell Disease Research
FSCDR is the leading U.S. organization solely dedicated to sickle cell disease. Its mission is to improve patient outcomes through innovative research, education, and clinical care.
